Quantitative Immunopeptidomics Reveals a Tumor Stroma–Specific Target for T Cell Therapy

To discover promising shared tumor antigens that could be targeted via T cell receptor-based adoptive T cell therapy, the authors employed population-scale immunopeptidomics using quantitative mass spectrometry across approximately 1500 tumor and normal tissue samples.